Cardiac damage in patients with COVID-19 coronavirus infection
N. G. Poteshkina,
M. A. Lysenko,
E. A. Kovalevskaya,
D. S. Fomina,
I. V. Samsonova,
V. V. Parshin,
O. V. Manchenko,
O. Y. Evsyukov https://doi.org/10.18705/1607-419X-2020-26-3-277-287
Abstract
The article reviews studies that confirm the relationship of a negative prognosis with the presence of risk factors for cardiovascular complications during respiratory infections, including novel coronavirus infection COVID-19. The article presents the relevant research results that provide evidence on the myocardial damage in coronavirus infection. We present a clinical case of a patient with confirmed diagnosis of COVID-19 and severe viral myocarditis, verified by histological and immunohistochemical studies.
About the Authors
N. G. Poteshkina
Pirogov Russian National Research Medical University; City Clinical Hospital № 52
Russian Federation
Russian Federation
Nataliya G. Poteshkina, MD, PhD, DSc, Professor, Head, Department for Internal Diseases, Faculty of Advanced Professional Training, Pirogov Russian National Research Medical University, Head, University Hospital, City Clinical Hospital № 52
1 Ostrovityanov street, Moscow, 117997
Phone: 8(499)194–04–37
M. A. Lysenko
Pirogov Russian National Research Medical University; City Clinical Hospital № 52
Russian Federation
Russian Federation
Maryana A. Lysenko, MD, PhD, DSc, Professor, Department for Internal Diseases, Faculty of Advanced Professional Training, Pirogov Russian National Research Medical University, Head Physician, City Clinical Hospital № 52
Moscow
E. A. Kovalevskaya
City Clinical Hospital № 52
Russian Federation
Russian Federation
Elena A. Kovalevskaya, MD, PhD, Head, Cardiology Department
Moscow
D. S. Fomina
City Clinical Hospital № 52; Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Daria S. Fomina, MD, PhD, Head, Centre of Allergology and Immunology, Department, City Clinical Hospital № 52, Associate Professor, Department for Clinical Allergology and Immunology, Sechenov First Moscow State Medical University, Head Out-ofStaff Specialist Allergist-Immunologist
Moscow
I. V. Samsonova
City Clinical Hospital № 52
Russian Federation
Russian Federation
Inna V. Samsonova, MD, PhD, Deputy Head Physician on Clinical Issues
Moscow
V. V. Parshin
City Clinical Hospital № 52
Russian Federation
Russian Federation
Vasiliy V. Parshin, MD, Head, Radiology Diagnostics Department
Moscow
O. V. Manchenko
City Clinical Hospital № 52
Russian Federation
Russian Federation
Oksana V. Manchenko, MD, PhD, Radiologist, X-ray Diagnostics Department
Moscow
O. Y. Evsyukov
City Clinical Hospital № 52
Russian Federation
Russian Federation
Oleg Y. Evsyukov, MD, PhD, Associate Professor, Department for Pathologic Anatomy, Pediatric Faculty, Pirogov Russian National Research Medical University, Pathologist, Department for Pathologic Anatomy, City Clinical Hospital № 52
Moscow
References
1. Всемирная организация здравоохранения. Глобальный сайт. [Электронный ресурс]. URL: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-thatcauses-it
2. Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281. doi:10.1001/jamacardio.2016.0433
3. Kwong JC, Schwartz KL, Campitelli MA, Chunget H, Crowcroft NS, Karnauchow T et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345–353. doi:10.1056/NEJMoa1702090
4. Martin-Rodriguez F, Lopez-Izquierdo R, Del Pozo Vegas C, Sanchez-Soberon I, Delgado-Benito JF, Martin-Conty JL et al. Can the prehospital National Early Warning Score 2 identify patients at risk of in-hospital early mortality? A prospective, multicenter cohort study. Heart Lung J Acute Crit Care. 2020;00(2020):1–7. doi:10.1016/j.hrtlng.2020.02.047
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S01406736(20)30183-5
6. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; e201017. doi:10.1001/jamacardio.2020.1017
7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020:e200950. doi:10.1001/jamacardio.2020.0950
8. Yuan X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
Review
For citations:
Poteshkina N.G., Lysenko M.A., Kovalevskaya E.A., Fomina D.S., Samsonova I.V., Parshin V.V., Manchenko O.V., Evsyukov O.Y. Cardiac damage in patients with COVID-19 coronavirus infection. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2020;26(3):277-287. (In Russ.) https://doi.org/10.18705/1607-419X-2020-26-3-277-287
Views:
2000
Email this article 